# US 2023/0053994 A1 · Methods for measuring gut permeability and gastric emptying rate

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0053994 A1
- Document ID: US20230053994A1
- Status: Published application
- Kind: A1
- Application number: 17/759,602
- Filed: 2021-01-29
- Published: 2023-02-23
- Earliest claimed: 2020-01-31
- Applicants: Imperial College Innovations Limited
- Inventors: Alexander J. THOMPSON
- Web page: https://patentgrep.com/patent/US20230053994A1

## CPC

- A61B 5/0071: {by measuring fluorescence emission}
- A61B 5/4238: {stomach}
- A61B 5/4255: {Intestines, colon or appendix}
- A61B 5/6813: {Specially adapted to be attached to a specific body part (A61B5/6802 takes precedence)}
- A61B 5/6824: {Arm or wrist}
- A61B 5/6826: {Finger}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A method for measuring gut permeability includes administering a solution including a fluorescent contrast agent to a subject; irradiating a location on the skin of the subject to cause a portion of the solution leaked into the bloodstream to fluoresce; obtaining fluorescence data of the intensity of the fluorescence as a function of time; normalising the fluorescence data to obtain normalised data of said intensity as a function of time; and analysing said normalised data to determine the gut permeability by calculating: (a) the first peak value of said intensity; (b) the integral of said intensity with respect to time; (c) the product of the first peak value of said intensity and the time at said peak value; (d) the time at which the first peak value of said intensity occurs; or (e) the first peak value of said intensity divided by the time at which said peak value occurs.

## Claims

### Claim 1

A method for measuring gut permeability of a subject, the method comprising:
orally administering a solution comprising a fluorescent contrast agent that is absorbable by a healthy gut to the subject;
using a light source to irradiate a location on the skin on a body part of the subject using light radiation, such that the light radiation causes at least a portion of the solution which has leaked out of the gut of the subject into the bloodstream of the subject to fluoresce;
using a transcutaneous sensing device to periodically detect the intensity of the fluorescence of the solution at said location to obtain fluorescence data of said intensity as a function of time;
normalising the fluorescence data to obtain normalised data of said intensity as a function of time; and
analysing said normalised data to determine the gut permeability of the subject by calculating one or more of:
a) the first peak value of said intensity;
b) the integral of said intensity with respect to time;
c) the product of the first peak value of said intensity and the time at said peak value;
d) the product of: the first peak value of said intensity, and the time at a point past the time of said first peak value;
e) the time at which the first peak value of said intensity occurs; or
f) the first peak value of said intensity divided by the time at which said peak value occurs.

### Claim 2 (depends on 1)

A method as claimed in claim 1, wherein the solution comprises water or juice.

### Claim 3 (depends on 1)

A method as claimed in claim 1, wherein the contrast agent comprises a dye, for example fluorescein, methylene blue or fluorescein isothiocyanate conjugated dextran, or salts thereof, or combinations thereof.

### Claim 4 (depends on 1)

A method as claimed in claim 1, wherein the transcutaneous sensing device has an acquisition time and the light source has an excitation power, and wherein the fluorescence data is normalised based on said acquisition time and said excitation power.

### Claim 5 (depends on 1)

A method as claimed in claim 1, wherein the transcutaneous sensing device begins taking periodic measurements before the solution is administered to the subject, such that the periodic detection of the intensity of the fluorescence of the solution begins before the solution is administered to the subject, to obtain a background signal to be used in the step of normalising the fluorescence data.

### Claim 6 (depends on 1)

A method as claimed in claim 1, wherein the light source comprises a light emitting diode or a laser.

### Claim 7 (depends on 1)

A method as claimed in claim 1, wherein the transcutaneous sensing device comprises one or more photodiodes, phototransistors and/or fibre-optic probes and is configured to be worn on and/or around said body part of the subject.

### Claim 8 (depends on 1)

A method as claimed in claim 1, wherein in the step of using the transcutaneous sensing device to periodically detect said intensity of the fluorescence, measurements are recorded by said transcutaneous sensing device at least once per minute.

### Claim 9 (depends on 1)

A method as claimed in claim 1, wherein said body part is a finger, wrist, arm or earlobe.

### Claim 10

A method for measuring gastric emptying rate of a subject, the method comprising:
orally administering a test meal comprising a fluorescent contrast agent that is absorbable by a healthy gut to the subject;
using a light source to irradiate a location on the skin on a body part of the subject using light radiation, such that the radiation causes at least a portion of the fluorescent contrast agent in the test meal which has been emptied from the stomach of the subject and has entered the bloodstream of the subject to fluoresce;
using a transcutaneous sensing device to periodically detect the intensity of the fluorescence of the fluorescent contrast agent in the test meal at said location to obtain data of said intensity as a function of time;
normalising the fluorescence data to obtain normalised data of said intensity as a function of time; and
analysing said normalised data to calculate the percentage of the test meal which is remaining in the stomach of the subject as a function of time, based on the intensity as a function of time divided by a peak value of the intensity.

### Claim 11 (depends on 10)

A method as claimed in claim 10, wherein the peak value of the intensity is the value of the intensity at a first peak or at a second peak in the fluorescence data, or is a maximum value of the intensity in the fluorescence data.

### Claim 12 (depends on 10)

A method as claimed in claim 10, wherein the test meal comprises a liquid test meal or a solid test meal.

### Claim 13 (depends on 10)

A method as claimed in claim 10, wherein the contrast agent comprises a dye, for example fluorescein, methylene blue or fluorescein isothiocyanate conjugated dextran, or salts thereof, or combinations thereof.

### Claim 14 (depends on 10)

A method as claimed in claim 10, wherein the transcutaneous sensing device has an acquisition time and the light source has an excitation power, and wherein the fluorescence data is normalised based on said acquisition time and said excitation power.

### Claim 15 (depends on 10)

A method as claimed in claim 10, wherein the transcutaneous sensing device begins taking periodic measurements before the test meal is administered to the subject, such that the periodic detection of the intensity of the fluorescence of the test meal begins before the test meal is administered to the subject, to obtain a background signal to be used in the step of normalising the fluorescence data.

### Claim 16 (depends on 10)

A method as claimed in claim 10, wherein the light source comprises a light emitting diode or a laser.

### Claim 17 (depends on 10)

A method as claimed in claim 10, wherein the transcutaneous sensing device comprises one or more photodiodes, phototransistors and/or fibre-optic probes and is configured to be worn on and/or around said body part of the subject.

### Claim 18 (depends on 10)

A method as claimed in claim 10, wherein in the step of using the transcutaneous sensing device to periodically detect said intensity of the fluorescence, measurements are recorded by said transcutaneous sensing device at least once per minute.

### Claim 19 (depends on 10)

A method as claimed in claim 10, wherein said body part is a finger, wrist, arm or earlobe.

### Claim 20 (depends on 10)

A method as claimed in claim 10, wherein the step of analysing said normalised data comprises fitting the function:
I
⁡
(
t
)
=
(
1
-
Ct
)
⁢
(
B
max
1
+
exp
⁢
(
-
k
B
(
t
-
t
B
⁢
1
2
)
)
+
L
max
1
+
exp
⁢
(
-
k
L
(
t
-
t
L
⁢
1
2
)
)
)
onto the normalised data using a numerical fitting procedure such as least squares fitting;
wherein:
t represents time;
I(t) represents the normalised data of said fluorescence intensity as a function of time;
Bmax represents the maximum value of the intensity contribution from the fluorescent contrast agent in the bloodstream of the subject as a function of time;
Lmax represents the maximum value of the intensity contribution from the fluorescent contrast agent that has leaked into the epithelium of the skin of the subject as a function of time;
tB1/2 represents the time at which the intensity contribution from the fluorescent contrast agent in the bloodstream of the subject as a function of time reaches half of its maximum value;
tL1/2 represents the time at which the intensity contribution from the fluorescent contrast agent that has leaked into the epithelium of the skin of the subject as a function of time reaches half of its maximum value;
C represents the rate at which dye is eliminated from the body of the subject;
kB is a constant and represents the logistic growth rate of the intensity contribution from the fluorescent contrast agent in the bloodstream of the subject as a function of time; and
kL is a constant and represents the logistic growth rate of the intensity contribution from the fluorescent contrast agent that has leaked into the epithelium of the skin of the subject as a function of time.

### Claim 21 (depends on 20)

A method as claimed in claim 20, wherein the step of analysing said normalised data further comprises calculating the amount of dye that has emptied from the stomach of the subject as a function of time, S(t), wherein S(t)=B(t)+B(t)Ct, wherein B(t) represents the intensity contribution from the fluorescent contrast agent in the bloodstream of the subject as a function of time.

### Claim 22 (depends on 21)

A method as claimed in claim 21, wherein the step of analysing said normalised data further comprises calculating the percentage of the test meal which is remaining in the stomach of the subject as a function of time, Rpc, wherein:
R
p
⁢
c
=
100
⨯
(
1
-
S
⁡
(
t
)
S
⁡
(
t
peak
)
)
and wherein S(tpeak) represents the value of S(t) at the time at which a final peak is observed in the normalised data of said intensity as a function of time.

### Claim 23 (depends on 20)

A method as claimed in claim 20, wherein the step of analysing said normalised data further comprises calculating the percentage of the test meal which is remaining in the stomach of the subject as a function of time, Rpc, wherein:
R
p
⁢
c
=
100
⨯
(
1
-
B
⁡
(
t
)
B
max
)
and wherein B(t) represents the intensity contribution from the fluorescent contrast agent in the bloodstream of the subject as a function of time.

### Claim 24 (depends on 10)

A method as claimed in claim 10, wherein the step of analysing said normalised data comprises calculating the percentage of the test meal which is remaining in the stomach of the subject as a function of time, Rpc, wherein:
R
p
⁢
c
=
100
⨯
(
1
-
I
⁡
(
t
)
I
⁡
(
t
peak
⁢
1
)
)
and wherein I(t) represents the normalised data of said intensity as a function of time; and
tpeak1 represents the time at which the first peak is observed in said intensity as a function of time.
